Indiplon-IR: NBIX completed enrollment of 500 patients in an interantional Phase III trial of indiplon-IR. The company plans to conduct a total of eight Phase I

Neurocrine Biosciences Inc. (NBIX), San Diego, Calif.
Product: Indiplon-IR

Read the full 90 word article

How to gain access

Continue reading with a
two-week free trial.